Fate Therapeutics Inc (FATE) insider trading
Every open-market stock purchase and sale by Fate Therapeutics Inc executives, directors, large shareholders and members of Congress, from SEC Form 4 filings. Sector: Other.
Insider activity at a glance
- Bahram Valamehr (CEO) and 1 other sold $204K in the last 90 days.
- Last insider buy: Redmile Group LLC (10% owner), $669K, 22 months ago.
Last 12 months: insiders bought $0 (0 buys) and sold $323K (6 sales). Last close $2.07 on Oct 21, 2026.
Recent FATE insider trades
| Date | Insider | Trade | Value |
|---|---|---|---|
| Aug 4, 2026 | Bahram Valamehr (CEO) | Sold | $108K |
| Aug 4, 2026 | Cindy Tahl (Insider) | Sold | $95.4K |
| Jun 12, 2026 | Matt Abernethy (Insider) | Bought (not open market) | — |
| Jun 12, 2026 | Shefali Agarwal (Insider) | Bought (not open market) | — |
| Jun 12, 2026 | Robert S Epstein (Insider) | Bought (not open market) | — |
| Jun 12, 2026 | Michael Stewart Lee (Director) | Bought (not open market) | — |
| Jun 12, 2026 | Laura Hamill (Insider) | Bought (not open market) | — |
| Jun 12, 2026 | William H Rastetter (Insider) | Bought (not open market) | — |
| Jun 12, 2026 | Karin Jooss (Insider) | Bought (not open market) | — |
| Jun 12, 2026 | Yuan Xu (Insider) | Bought (not open market) | — |
| Jun 12, 2026 | Redmile Group LLC (10% owner) | Bought (not open market) | — |
| May 20, 2026 | Bahram Valamehr (CEO) | Sold | $54.5K |
| May 20, 2026 | Cindy Tahl (Insider) | Sold | $48.1K |
| May 6, 2026 | Cindy Tahl (Insider) | Bought (not open market) | — |
| May 6, 2026 | Cindy Tahl (Insider) | Bought (not open market) | — |
| May 5, 2026 | William H Rastetter (Insider) | Bought (not open market) | — |
| May 5, 2026 | Robert S Epstein (Insider) | Bought (not open market) | — |
| Apr 20, 2026 | Redmile Group LLC (10% owner) | Bought (not open market) | — |
| Apr 20, 2026 | Redmile Group LLC (10% owner) | Bought (not open market) | — |
| Apr 20, 2026 | Redmile Group LLC (10% owner) | Bought (not open market) | — |
| Apr 20, 2026 | Redmile Group LLC (10% owner) | Bought (not open market) | — |
| Apr 20, 2026 | Redmile Group LLC (10% owner) | Bought (not open market) | — |
| Jan 15, 2026 | Cindy Tahl (Insider) | Bought (not open market) | — |
| Jan 15, 2026 | Bahram Valamehr (CEO) | Bought (not open market) | — |
| Jan 15, 2026 | Kamal Adawi (CFO) | Bought (not open market) | — |
Who's trading FATE
- Bahram Valamehr, CEO: sold $168K (3 sales), last Aug 4, 2026
- Cindy Tahl, Insider: sold $155K (3 sales), last Aug 4, 2026
- Yuan Xu, Insider: other filings, last Jun 12, 2026
- Shefali Agarwal, Insider: other filings, last Jun 12, 2026
- Robert S Epstein, Insider: other filings, last Jun 12, 2026
- Laura Hamill, Insider: other filings, last Jun 12, 2026
- Karin Jooss, Insider: other filings, last Jun 12, 2026
- Michael Stewart Lee, Director: other filings, last Jun 12, 2026
- William H Rastetter, Insider: other filings, last Jun 12, 2026
- Redmile Group LLC, 10% owner: other filings, last Jun 12, 2026
- Matt Abernethy, Insider: other filings, last Jun 12, 2026
- Kamal Adawi, CFO: other filings, last Jan 15, 2026
Get free alerts when an insider at Fate Therapeutics Inc files a new trade →